Table 2.
Characterization of Blank-NPs, Cur-NPs, Blank-P-NPs, and Cur-P-NPs
| Particle Size (nm) | PDI | Zeta Potential (mV) | EE (%) | DL (%) | |
|---|---|---|---|---|---|
| Blank-NPs | 142.4 ± 0.1414 | 0.164 ± 0.045 | −8.76 ± 0.311 | - | - |
| Cur-NPs | 148.1 ± 5.869 | 0.211 ± 0.016 | −10.0 ± 0.304 | 71.19 ± 0.529 | 4.25 ± 0.438 |
| Blank-P-NPs | 150.9 ± 2.121 | 0.227 ± 0.021 | 10.1 ± 0.247 | - | - |
| Cur-P-NPs | 148.3 ± 2.192 | 0.199 ± 0.053 | 12.4 ± 0.0707 | 74.66 ± 0.671 | 5.38 ± 0.316 |
Abbreviations: Blank-NPs, blank hybridized nanoparticles; Cur-NP, Cur-loaded hybridized nanoparticles; Blank-P-NPs, blank enzyme-targeted hybridized nanoparticles; Cur-P-NPs, Cur-loaded enzyme-targeted hybrid nano-delivery systems; EE, entrapment efficiency; PDI, polydispersity index; DL, drug loading.